SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-021934
Filing Date
2021-03-18
Accepted
2021-03-18 20:27:04
Documents
2
Period of Report
2021-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3988
2 POA DOCUMENT poa.txt EX-24.4_974400 2915
  Complete submission text file 0001209191-21-021934.txt   8382
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Issuer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NGM BIOPHARMACEUTICALS, INC. 333 OYSTER POINT PKWY SOUTH SAN FRANCISCO CA 94080
Business Address
Lieu Hsiao D (Reporting) CIK: 0001468482 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38853 | Film No.: 21756173